Home / Products / Medicinal Products / Montel (5 mg)

Montel (5 mg) Montelukast / R03D C03
Montel (5 mg)

Montelukast / R03D C03

Active ingredients:

Montelukast 5 mg.

MONTELUKAST is a leukotriene receptor antagonist (LTRA) that inhibits the cysteinyl leukotriene CysLT1 receptor.

Indications

For paediatric patients from 6 to 14 years of age:

MONTELUKAST is used in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” shortacting β-agonists provide inadequate clinical control of asthma.

MONTELUKAST may also be an alternative treatment option to low-dose inhaled corticosteroids for patients with mild persistent asthma who do not have a recent history of serious asthma attacks that required oral corticosteroid use and who have demonstrated that they are not capable of using inhaled corticosteroids.

MONTELUKAST is also used in the prophylaxis of asthma in which the predominant component is exercise-induced broncho-constriction.

MONTELUKAST can also provide symptomatic relief of seasonal allergic rhinitis.

Dosage and pharmaceutical form:

chewable tablets 5 mg, 7 tablets in blister, 4 blisters in package.

Another products:

Montel (4 mg)

Montel (10 mg)